henhaobio
Sign in

Brain PathologyNeurosciencePeer-reviewed journal article

Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell lines

Paz Cartas‐CejudoiD, Marina De Miguel, Leire ExtramianaiD, Mercedes Lachén‐MontesiD, Silvia Romero-MurilloiD, Djordje O. GvericiD, Joaquín Fernández‐IrigoyeniD, Enrique SantamaríaiD

PDFDOIPreprint

Abstract

Parkinsons disease (PD) is the second most common neurodegenerative disorder mainly characterized by the degeneration of dopaminergic neurons originating in the substantia nigra (SN) pars compacta and projecting to other brain regions, giving rise to motor and non-motor symptoms. Despite significant progress in understanding the molecular and cellular disruptions associated with PD, there remains an unmet clinical need for effective therapies. In this study, proteomic analysis of the olfactory tract (OT) in controls with no known neurological history (n=17) and PD subjects (n=21) revealed Lewy body disease (LBD) stage-dependent proteostatic impairment, accompanied by progressive modulation of the alpha-synuclein (-syn) functional interactome. Differential OT omic profiles (OMS) were used in a computational drug repurposing approach, reveling the HDAC1 inhibitor pyroxamide as one of the top drug candidates with in silico potential to restore altered OMS. To explore the potential therapeutic effects of pyroxamide, in vitro assays were performed using -syn preformed fibrils (PFFs). Pyroxamide treatment reduced -syn PFFs-induced toxicity in olfactory epithelial, microglial and dopaminergic neuronal cell lines, producing a protective effect against hydrogen peroxide-induced damage exclusively in brain-derived cell types. These findings confirm the suitability of omics profiles in drug repurposing workflows against PD, offering valuable insights into the potential of HDAC1 inhibitors in the therapeutic pipeline of PD. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=54 SRC="FIGDIR/small/679944v1_ufig1.gif" ALT="Figure 1"> View larger version (14K): org.highwire.dtl.DTLVardef@1e7a8e8org.highwire.dtl.DTLVardef@229c2org.highwire.dtl.DTLVardef@39f5corg.highwire.dtl.DTLVardef@1d35105_HPS_FORMAT_FIGEXP M_FIG C_FIG

Citations
0
FWCI
0.00
Field percentile
top 34%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISMasato '21Shonai '26Reintsch '26Kumar '22Chiara '21Neupane '26
68% semantic matchNeuroscience
Anna Masato, Nicoletta Plotegher, Andrea Thor+13 more·bioRxiv·Jun 15, 2021· 3 citations